Drug Shortage Report for TREANDA
| Report ID | 244075 |
| Drug Identification Number | 02392569 |
| Brand name | TREANDA |
| Common or Proper name | TREANDA 100MG/20ML FOR INJECTION |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | BENDAMUSTINE HYDROCHLORIDE |
| Strength(s) | 100MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 20ML |
| ATC code | L01AA |
| ATC description | ALKYLATINGAGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-11-27 |
| Estimated end date | 2025-05-20 |
| Actual end date | 2025-05-01 |
| Shortage status | Resolved |
| Updated date | 2025-05-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-12-20 | English | Compare |
| v2 | 2024-11-28 | French | Compare |
| v1 | 2024-11-28 | English | Compare |